Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
Study Information
Alliance Study ID: CALGB-9473
NCT Study ID (ClinicalTrials.gov): NCT00003077
Alliance Committee: Cancer Control
Disease or Cancer Type: Other Cancer
Alliance Study Chair: C. Patrick Burns, MD
Status: COMPLETED
Study Description
RATIONALE: Omega-3 fatty acids are used by the body for energy and tissue development and may be an effective treatment for patients with advanced cancer who are unable to maintain their body weight.
PURPOSE: Phase I/II trial to study the effectiveness of omega-3 fatty acids in treating patients with advanced cancer who have significant weight loss.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information